|
2024 |
2023 |
|||||||
(dollars in millions) |
Q1 |
Q4 |
Q1 |
||||||
Adjusted EBITDA |
$ |
28.3 |
|
$ |
23.4 |
|
$ |
35.1 |
|
Divided by Total Net Sales |
|
213.4 |
|
|
204.6 |
|
|
243.8 |
|
Adjusted EBITDA Margin |
|
13.3 |
% |
|
11.4 |
% |
|
14.4 |
% |
*Values in table may not add due to rounding. |
|||||||||
Reconciliation of Net Cash Provided By (Used In) Operating Activities to Free Cash Flow*:
|
2024 |
2023 |
|||||||
(dollars in millions) |
Q1 |
Q4 |
Q1 |
||||||
Net Cash Provided By (Used In) Operating Activities |
$ |
28.1 |
|
$ |
71.9 |
|
|
1.8 |
|
Non-Acquisition Capital Expenditures |
|
(9.4 |
) |
|
(22.5 |
) |
|
(16.4 |
) |
Free Cash Flow |
$ |
18.7 |
|
$ |
49.4 |
|
$ |
(14.6 |
) |
| *Values in table may not add due to rounding. |
|||||||||
